Mountaintop Autism Partners Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 175 Needle Creek Rd, Divide, CO 80814 Phone: 703-789-5660 |
Mountaintop Autism Partners Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 175 Needle Creek Rd, Divide, CO 80814 Phone: 703-789-5660 |
Bloom Wellness Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 417 Beaver Pond Rd, Divide, CO 80814 Phone: 303-408-8056 |
News Archive
Depression and schizophrenia can be triggered by environmental stimuli and often occur in response to stressful life events. However, some people have a higher predisposition to develop these diseases, which highlights a role for genetics in determining a person's disease risk.
Repligen Corporation announced today that the United States Patent and Trademark Office has granted a Notice of Allowance of a patent covering the use of uridine in the treatment of patients with bipolar disorder. The patent, which upon issue will remain in force until 2025 prior to any patent term extensions, covers the use of an effective dose of a uridine composition to improve one or more of the symptoms of bipolar disorder including depression, mania, mixed episodes, hypomania and anxiety.
A research team from the University of Valencia, led by Professor Juan Saus from the Department of Biochemistry and Molecular Biology, is developing a project to provide the healthcare system with a diagnostic test that anticipates the entry into advanced stages of patients with COVID-19 and a scalable oral treatment for the disease.
A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status.
› Verified 5 days ago